A third COVID vaccine dose improves defense for some clinically extremely vulnerable patients

A third COVID vaccine dose improves defense for some clinically extremely vulnerable patients

A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against COVID-19.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *